AI-powered diagnostics enhance reproducibility, ensuring consistent results across labs, which is crucial for equitable patient care.
2
AI provides more accurate quantitative results than traditional methods, ensuring patients receive appropriate therapies based on precise cutoff thresholds.
3
AI can analyze complex cellular data beyond human capabilities, improving biomarker identification and therapy selection for individual patients.
4
Multimodal biomarkers powered by AI can optimize patient selection strategies by integrating diverse data sources for personalized treatment.
5
Collaboration with tech giants and regulatory clarity are essential for advancing AI diagnostics and ensuring equitable access to innovative therapies.
